Skip to content
Home/Companies/Healthcare/Vernacare

Vernacare

Healthcare·UK·Exited 2020·Held 5yr
Entry
2015
Hold
5yr
Exit
2020

Who owns Vernacare?

Vernacare was owned by Palatine Private Equity through Palatine Buyout Fund III (2015 vintage) from 2015 to 2020, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Palatine Private Equity
Investor
Palatine Private Equity
Palatine Buyout Fund III · 2015 · Buyout

Key facts

HQUnited Kingdom
SectorHealthcare
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2020

More from Palatine Buyout Fund III

Other portfolio companies in the same fund.

Acora
Acora
Exited 2022
IT ServicesUK· 2020
to
Direct Tyre Management (DTM)
Exited 2024
Business ServicesUK· 2020
to
Lucion Services
Lucion Services
Active
Business ServicesUK· 2019
Suntera Global
Suntera Global
Exited 2025
FinancialsUK· 2019
to
CET
CET
Exited 2021
InsurTechUK· 2018
to
CTS
CTS
Exited 2022
Business ServicesUK· 2018
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Vernacare

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Vernacare?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Vernacare.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue